Intracranial Aneurysm Market - Top Companies and Manufacturers

In the News

• In May 2023, Stryker, one of the world's leading medical technology companies, announced that it completed the acquisition of Cerus Endovascular Ltd., a privately held, commercial-stage medical device company engaged in the design and development of neurointerventional devices for the treatment of intracranial aneurysms.
• In April 2021, Medtronic plc a global leader in medical technology, received approval from the United States Food and Drug Administration (FDA) for its Pipeline Flex Embolization Device with Shield Technology. Medtronic developed Shield Technology, a proprietary breakthrough in biomaterial science, to advance flow diversion therapy by introducing the first surface-modified implant device with reduced material thrombogenicity, or the ability of the surface treatment material to form clots. NYU Langone Health in novel York City completed the nation's first patient procedure with the novel technology.